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A bacterial collagen-like protein Scl2 has been developed as a
recombinant collagen model system to host human collagen
ligand-binding sequences, with the goal of generating biomate-
rials with selective collagen bioactivities. Defined binding sites
in human collagen for integrins, fibronectin, heparin, and
MMP-1 have been introduced into the triple-helical domain of
the bacterial collagen and led to the expected biological activi-
ties. The modular insertion of activities is extended here to the
discoidin domain receptors (DDRs), which are collagen-acti-
vated receptor tyrosine kinases. Insertion of the DDR-binding
sequence from human collagen III into bacterial collagen led to
specific receptor binding. However, even at the highest testable
concentrations, the construct was unable to stimulate DDR
autophosphorylation. The recombinant collagen expressed in
Escherichia coli does not contain hydroxyproline (Hyp), and
complementary synthetic peptide studies showed that replace-
ment of Hyp by Pro at the critical Gly-Val-Met-Gly-Phe-Hyp
position decreased the DDR-binding affinity and consequently
required a higher concentration for the induction of receptor
activation. The ability of the recombinant bacterial collagen to
bind the DDRs without inducing kinase activation suggested it
could interfere with the interactions between animal collagen
and the DDRs, and such an inhibitory role was confirmed in
vitro and with a cell migration assay. This study illustrates that
recombinant collagen can complement synthetic peptides in
investigating structure-activity relationships, and this system
has the potential for the introduction or inhibition of specific
biological activities.
Genomic studies of prokaryotic organisms identified more
than 100 genes that encode proteins with collagen-like (Gly-
Xaa-Yaa)n repeating sequences (1). A number of these bacterial
collagen-like proteins have been expressed in recombinant sys-
tems, and all formed triple-helical structureswith stability close
to the Tm  37 °C found for mammalian collagens (2). These
proteins lack the post-translationalmodification of Pro to 4-hy-
droxyproline (Hyp),5 which is essential for triple helix stabiliza-
tion in animal collagens, and alternative stabilization strategies
are utilized (3, 4). Pure bacterial collagen-like proteins can be
produced in high yield in a recombinant Escherichia coli system
where their sequences can be easily modified, making them an
attractive source of recombinant collagenous material for bio-
engineering and biomedical applications (5–7). One collagen-
like protein, Scl2 (Streptococcus collagen-like protein 2) from
the Gram-positive bacterium Streptococcus pyogenes, has been
extensively characterized (8, 9). The Scl2 collagen domain
appears to be biologically inert, making it an excellent “blank
slate” framework for the introduction of specific activities
found in animal collagens (5, 10, 11). Human collagens are
known to interact with cell surface receptors, extracellular
matrix proteins, proteoglycans, glycosaminoglycans, and en-
zymes, and the specific (Gly-Xaa-Yaa)n sequences responsible
for an increasing number of interactions have been determined
through protein and synthetic peptide studies (12–17). Identi-
fication of specific ligand binding sequences in human collagen
presents an opportunity to insert defined biological activities in
a stable triple-helical scaffold provided by recombinant bacte-
rial collagens such as Scl2.
The development of a recombinant bacterial collagen system
with inserted human bioactivities depends on amodular model
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of collagen activity, where a specific (Gly-Xaa-Yaa)n-binding
motif is responsible for a given bioactivity. Typically, short
sequences of tripeptides (Gly-Xaa-Yaa)n, where n  2 to 6,
define a ligand-binding site, and experiments introducing the
sequences for recognizing integrins, fibronectin, and heparin
into the Scl2 triple-helical domain have demonstrated the
expected biological activity, both in solid state binding assays
and cell culture studies (11, 18–20). In addition, insertion of the
sequence for the unique human matrix metalloproteinase
cleavage site of type III collagen led to specific digestion of the
recombinant collagen protein at this site (21). Here, we extend
the concept of designing modular recombinant collagen with
separate collagen functionalities by introducing a high affinity
binding site for the discoidin domain receptors (DDRs), which
are collagen-activated receptor tyrosine kinases (22).
The cell surface DDR receptors are widely expressed in
human tissues and play key roles in the communication of cells
with the extracellular matrix. The DDRs regulate fundamental
cellular functions, including cell adhesion, proliferation, and
migration (22, 23). The DDR family consists of two closely
related receptors, DDR1 andDDR2, that are both activated by a
number of different collagen types, in particular fibrillar colla-
gens (24, 25). Both receptors play important roles in embryo
development, and alterations in DDR function have been
related to organ fibrosis, osteoarthritis, and tumor progression
(22, 26, 27). Collagen binding to their discoidin homology
domain induces receptor autophosphorylationwith slow kinet-
ics (24, 25, 28). DDR binding to collagen requires its presenta-
tion as a native triple-helical structure. Studies using synthetic
triple-helical collagen-mimetic peptides demonstrated that the
major binding site for DDR1 and DDR2 in the interstitial fibril-
lar collagen types I–III contains an essential GVMGFO motif
(where O  Hyp) (29, 30). A crystal structure of the discoidin
domain of human DDR2 bound to a triple-helical peptide
revealed the DDR-collagen (GVMGFO) interface at atomic
level resolution (31). Peptide studies indicated additional bind-
ing sites, with sequences other than GVMGFO, in the fibrillar
collagens for DDR2 but not DDR1 (29, 30).
The goal of this work was to exploit modular designs of bac-
terial collagens to study interactions with the DDRs. A human
type III collagen sequence containing the GVMGFO-based
DDR-binding site, conserved in collagen II and the 1 chain of
collagen I, was inserted between two triple-helical domains of
the bacterial Scl2 sequence. Solid-phase binding assays demon-
strated that this recombinant collagen protein bound to recom-
binant DDR ectodomains, as expected. However, the engi-
neered bacterial collagen did not induce DDR activation, as
assessed by receptor autophosphorylation, suggesting a more
complicated story than simple modular activity. The produc-
tion of a recombinant collagen, which could bind to but not
activate DDR receptors, raised the possible utility of such con-
structs as DDR inhibitors, and this inhibitory effect was dem-
onstrated in both a competitive binding assay as well as in
megakaryocyte (Mk) migration assays.
Experimental Procedures
Chemicals used in all experiments were purchased from
Sigma unless otherwise indicated. Collagens type I and type III
preparations, provided by Dr. John Ramshaw, were pepsin-ex-
tracted from bovine skin as described (32). Hemate P (Aventis-
Behring, Milan, Italy), which contains high purity human von
Willebrand factor (VWF) and FVIII, was used as-is in the VWF
binding assay.
Production of Recombinant Bacterial Collagen Proteins—The
protein sequence for the bacterial collagen constructs was
based on the original Scl2.28 sequence from S. pyogenes (9). The
original protein constructwith theN-terminal globular domain
(V) was modified to include the following: two tandem repeats
of the triple-helical domain (CL); an N-terminal hexahistidine
tag for purification; and a protease-susceptible sequence
(LVPRGSP) between the V and the first CL domains for V
domain removal, as described previously (19, 33). Oligonucleo-
tides encoding the type III collagen DDR-binding sequence
were designed and synthesized (Invitrogen; sequences provided
upon request). These were inserted as annealed dsDNA be-
tween the two CL domains of the bacterial collagen constructs
through restriction sites XmaI and ApaI included in the oligo-
nucleotide sequences. The final constructs containing the
DDR-binding sites were cloned into the pColdIII vector
(Takara Bio Inc.) through NdeI and BamHI restriction sites.
All enzymes for cloning were purchased from New England
Biolabs. DNA sequencing to confirm fidelity was carried out
at the Tufts Core Facility. The DNA constructs and their sub-
sequent proteins were denoted as SCl, for Streptococcus colla-
gen-like proteins. The recombinant SCl proteins containing
DDR-binding sequences were denoted as SCl-DDR4 (inserted
sequence, GPRGQPGVMGFP), SCl-DDR6 (inserted sequence,
GPSGPRGQPGVMGFPGPK), and SCl-DDR6 F-A (inserted se-
quence, GPSGPRGQPGVMGAPGPK), respectively. The bac-
terial collagen sequences immediately flanking the inserted
human DDR-binding sequences were. . .GKDGQPGKP (Inser-
tion) GPRGEQGPT. . . .
All SCl constructs in the pColdIII vector were expressed in
E. coli BL21 strain, grown in 20 ml of LB medium with 100
g/ml ampicillin overnight at 37 °C. This starting culture
was used to inoculate 500 ml of LB/ampicillin media in a shak-
ing flask and grown at 37 °C to an A600 nm  0.8. To induce
protein expression, 1 mM isopropyl -D-thiogalactopyranoside
(Thermo Scientific) was added to the culture, and the temper-
ature was lowered to 22 °C. After 16 h of induction, cells were
harvested by centrifugation and resuspended inHis tag column
binding buffer (20 mM sodium phosphate buffer, pH 7.4, 500
mM NaCl, 10 mM imidazole) containing 0.25 mg/ml lysozyme
and frozen at80 °C until purification. Purification of the His-
tagged SCl proteins was carried out by affinity chromatography
with nickel ion binding and imidazole gradient elution on an
ÄKTA pure 25L FPLC (GE Healthcare). Frozen cells were
thawed and further lysed by sonication. Cellular debris was
removed by centrifugation at 8000 g at 4 °C. The supernatant
containing the soluble target protein was injected onto binding
buffer equilibrated 5-mlHisTrapHP columns (GEHealthcare).
The column was then washed sequentially with 3 column vol-
umes of binding buffer, binding buffer plus 50 mM imidazole,
and binding buffer plus 100 mM of imidazole. The His-tagged
protein was eluted by elution buffer (binding buffer plus 400
mM imidazole). Protein purity was checked by SDS-PAGE
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(NuPAGE BisTris 4–12%, Invitrogen). The protein concen-
trationwas determined using an extinction coefficient of 280
9970 M1 cm1 after dialysis into phosphate-buffered saline
(PBS, pH 7.4).
Production of Recombinant DDR Ectodomain Proteins—The
production and purification of recombinant human DDR pro-
teins were as described previously (30). The Fc-tagged DDR1
(DDR1-Fc, with IgG2 sequence) and DDR2 (DDR2-Fc with
IgG2 sequence) were isolated from episomally transfected
HEK293-EBNA cells. Proteins were purified by affinity chro-
matography on HiTrap rProtein A column using an ÄKTATM
purifier (GE Healthcare). For some experiments, human DDR1-
Fc (with IgG1 sequence) was purchased from R&D Systems
(Minneapolis, MN).
Peptide Synthesis—The sequences of the peptides used in this
study were as follows: GPC(GPP)5-GPRGQOGVMGFO-(GPP)5
GPC-NH2; GPC(GPP)5-GPRGQPGVMGFO-(GPP)5GPC-
NH2; GPC(GPP)5-GPRGQOGVMGFP-(GPP)5GPC-NH2;
GPC(GPP)5-GPSGPRGQOGVMGFO-(GPP)5GPC-NH2;
GPC(GPP)5-GPSGARGQOGVMGFO-(GPP)5GPC-NH2; GPC
(GPP)5-GPSGPRGQAGVMGFO-(GPP)5GPC-NH2; GPC(GPP)5-
GPSGPRGQOGVMGFA-(GPP)5GPC-NH2; and GPC(GPP)10-
GPC-NH2. Peptides were synthesized by Fmoc (N-(9-flu-
orenyl)methoxycarbonyl) chemistry as C-terminal amides on
TentaGel R RAMresin in either anApplied Biosystems Pioneer
or amicrowave-assisted CEMLiberty Discover automated syn-
thesizer, and purified as described (34). Peptides were verified
by mass spectrometry and shown to adopt triple-helical
conformation by polarimetry.
Mass Spectrometry—Matrix-assisted laser desorption/ioni-
zation time of flightmass spectrometry (MALDI-TOFMS) was
performed on a Microflex LT system (Bruker Corp., Billerica,
MA)with 50% laser intensity using standard LP (linear positive)
60-kDa mode provided by the software. MALDI matrix was
prepared by making a saturated sinapinic acid solution in 50%
(v/v) acetonitrile and 0.3% (v/v) trifluoroacetic acid. A 6-l ali-
quot of 1g/ml samplewasmixedwith 24l ofmatrix, and 1l
of this solution was plated onto a 96 spot target plate and
allowed to dry before spectra acquisition.
Trypsin Digestion—Purified SCl proteins in PBS buffer were
incubated with 0.01 mg/ml (430 nM) trypsin at 25 °C for 120
min. The reaction was stopped by addition of phenylmethyl-
sulfonyl fluoride (PMSF) to 1 mM. Cleavage was visualized by
SDS-PAGE.
Circular Dichroism—CD spectra were obtained on AVIV
model 420CD spectrometer (AVIVBiomedical, Lakewood, NJ)
using glass cuvettes with a 1-mm path length. Protein solutions
were equilibrated for at least 24 h at 4 °C before measurement.
Wavelength scanswere collected from190 to 260 nm in 0.5-nm
stepswith a 4-s averaging time, 1.0 nmbandwidth, and repeated
three times. Temperature scans were monitored from 15 to
70 °C at 225 nm with a 10-s averaging time and a 1.5-nm band-
width. Samples were equilibrated for 2 min at each tempera-
ture, and the temperature was increased at an average rate of
0.1 °C/min.
Differential Scanning Calorimetry—Differential scanning
calorimetry was performed on a NANO DSC II model 6100
(Calorimetry Sciences Corp, Lindon, UT). Each sample was re-
dialyzed against PBS overnight before measurement to collect
the dialyzed buffer as reference in the experiment. Sample solu-
tions were loaded at 0 °C into the cell and heated at a rate of
1 °C/min until 100 °C.
Dynamic Light Scattering—DLS measurements were per-
formed using a DynaPro Titan instrument (Wyatt Technology
Corp., Santa Barbara, CA) equipped with a temperature con-
troller using Eppendorf UVette cuvettes with 10-mm path
length. Protein concentrations of the samples (in PBS) were
adjusted to 1mg/ml. Sampleswere centrifuged at 14,000 g for
10 min and filtered through 0.2-m Whatman Anotop 10
syringe filters before measurement. Samples were measured at
80% laser intensity. Twenty acquisitions were taken for every
sample with each acquisition lasting 60 s. To obtain the hydro-
dynamic radius (Rh), the intensity autocorrelation functions
were analyzed by Dynamic software.
Solid-phase Binding Assays—The binding of recombinant
DDR-Fc proteins to immobilized collagen proteins was mea-
sured using a solid-phase binding assay. 50 l of 200 g/ml
collagen samples in PBS were coated onto Immulon 2HB
96-well assay plates (ThermoFisher Scientific, Waltham, MA)
overnight at 4 °C. Denatured samples were first incubated in a
90 °C water bath for 30 min before coating. Plates were washed
and blocked by 1 mg/ml BSA in PBS with 0.05% Tween 20
(PBS-T) for 1 h at room temperature. 50 l of recombinant
DDR1-Fc or DDR2-Fc was subsequently added to each colla-
gen-coated well at a concentration of 20 g/ml (220 nM) in
PBS and incubated for 3 h at room temperature. For dose-re-
sponse assays, serial concentrations of DDR-Fc at 60, 20, 6, 2,
0.6, 0.3, 0.15, 0.06, 0.03, 0.015, and 0 g/ml were used, which
correspond to667, 222, 67, 22, 6.7, 3.3, 1.7, 0.7, 0.3, and 0.17
nM DDR-Fc in molar concentration. For competitive binding
assays, the plates were coated with 50 l of 10 g/ml bovine
collagen type III overnight at 4 °C, washed, and blocked as
described above. A final concentration of 3 g/ml (43 nM)
DDR-Fc wasmixed and incubated with each collagen sample at
a final molar concentration of 0, 0.3, 1.3, 5, and 10 M for 1 h at
room temperature. 50l of the collagen/DDR-Fcmixtures was
subsequently added onto the type III collagen-coated plates and
incubated at room temperature for 3 h. Bound DDR-Fc on the
plates was detected by incubating first with primary antibody as
follows: mouse anti-human IgG1 Fc mAb (Clone 97924, R&D
Systems, Minneapolis, MN) at 1 g/ml; and then secondary
antibody as follows: anti-mouseHRP antibody (SantaCruz Bio-
technology, Dallas, TX) at 1:2,000 dilution, each for 1 h. Finally,
50 l of 3,3,5,5-tetramethylbenzidine solution (Invitrogen)
was added for the colorimetric reaction. Plates were washed
with 200 l of PBS-T 6 times between every step. Color was
allowed to develop at room temperature for 5 min, and 50 l of
1 M HCl was added to stop the reaction. A450 nm was recorded
from the 96-well plate using a Spectra Max M2 plate reader
(Molecular Devices, Sunnyvale, CA) for data analysis. Appro-
priate controls were included using the same setup. The VWF
binding assay was carried out using the same mass concentra-
tions as DDR-Fc binding assays. For VWF detection, rabbit
anti-VWFN-terminal antibodies (1:1000) and anti-rabbit HRP
antibodies (1:5000) (Abcam) were used. Binding of DDR1-Fc
and DDR2-Fc to chemically synthesized triple-helical peptides
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was performed using a similar protocol, as described previ-
ously, with detection of bound proteins using anti-human Fc
coupled to horseradish peroxidase and o-phenylenediamine
dihydrochloride as a substrate (29, 30).
Collagen-induced DDR Activation Assays—Collagen-in-
duced DDR autophosphorylation in HEK293 cells was per-
formed as described (28–30). Transiently transfected cellswere
stimulated with collagen I or peptides for the indicated times
and temperature, and cell lysates were analyzed by Western
blotting with mouse anti-phosphotyrosine monoclonal anti-
body (clone 4G10 from Upstate Biotechnology), goat anti-
DDR2 (AF2538 from R&D Systems), or rabbit anti-DDR1
(SC-532 from Santa Cruz Biotechnology) and appropriate
HRP-conjugated secondary antibodies. The DDR activation
assay on Mks was performed as follows. Mks were differenti-
ated from cord blood-derived CD34 cells for 13 days in
StemSpan medium (Stem Cell, Vancouver, Canada) supple-
mented with 10 ng/ml thrombopoietin, 10 ng/ml IL-11 (Pepro-
Tech, London, UK), 1% L-glutamine, and 1% penicillin/strepto-
mycin as described previously (35). Mks (7  105) at day 13 of
differentiation were plated on 25 g/ml type III collagen-
coated 6-well plates upon 30min of incubation with 100 g/ml
(580 nM) of the indicated bacterial collagen. In parallel,
unstimulated Mks were plated on uncoated wells as control.
After 8 h of incubation at 37 °C in a 5% CO2 fully humidified
atmosphere, Mks were lysed by scraping the well as described
previously (36). Lysates were used forWestern blotting analysis
of DDR1 activation. Membranes were stained with anti-phos-
pho DDR1 (Tyr-792; Cell Signaling, Danvers, MA) and anti-
actin (Sigma, Milan, Italy) to show equal loading.
Megakaryocytes Migration Assay—Mk migration and inva-
sion assays were performed as described previously (36).
Briefly, 8-m trans-well migration inserts (Millipore) were
coated with 25 g/ml type III collagen overnight at 4 °C. Mks
(25 103) were seeded on the upper well in 100l of StemSpan
and incubated at 37 °C and 5% CO2. After 16 h, Mks that had
passed through the trans-well to the other side of the filters and
in the outerwells, which contained StemSpanmediumwith 100
ng/ml SDF1- (PeproTech, London, UK), were recovered and
counted under an inverted microscope. Thereafter, the upper
side of the filters was carefully washed with cold PBS, and cells
remaining on the upper face of the filters were removed with a
cotton wool swab. Trans-well filters were fixed in 4% para-
formaldehyde for 20 min at room temperature, stained using a
monoclonal antibody against CD61 (Santa Cruz Biotechnol-
ogy) and with Hoechst 33258, cut out with a scalpel, and
mounted onto glass slides, putting the lower face on the top.
Each experiment was performed in at least triplicates. Data are
expressed as numbers of total migrated cells per insert or as
percentages of cells related to that of the control. Images were
acquired using an Olympus BX51 using 20/0.5 UPlanF1
objective.
Data Analysis—Quantitative analyses were performed in
triplicate, with results based on the averages of data points and
standard deviations presented as error bars. However, the
experiments for the dose-response curves consisted of dupli-
cate or single measurements, to measure all samples on the
same 96-well plate. In this case, three independent repeat
experiments were performed to confirm the consistency of
results. The significance level was determined by p value using
paired-sample Student’s t test between the means of two sam-
ples. p  0.05 is considered significant. Raw data were pro-
cessed and plotted in either Origin 6.0 (MicroCal Inc.), Excel
2013 (Microsoft Corp.) or Prism (GraphPad Software, Inc).
Results
Design and Expression of Recombinant Bacterial Collagen
with a DDR-binding Motif—A major DDR-binding site con-
tained in fibrillar collagens I–III is the six amino acid motif
GVMGFO, which was identified using triple-helical synthetic
collagen-mimetic peptides (29, 30). Although these six amino
acids are sufficient for binding recombinantDDR ectodomains,
as assessed by solid-phase binding assays, the activation of full-
length receptors on the surface of cells requires the presence of
additional amino acids N-terminal to the GVMGFO motif;
peptides presenting GPRGQOGVMGFO (human type III
collagen sequence) induce DDR autophosphorylation with
similar kinetics to full-length collagen (29). For this study, we
modified streptococcal bacterial collagen Scl2.28, by recombi-
nant DNA technology to insert the DDR-binding sequences
from human type III collagen. Sequences from the homotrim-
eric human 1(III) chain were used because the bacterial sys-
temproduces homotrimers. TheGVMGFOmotif is completely
conserved among the fibrillar types II and III collagens and the
1 chains of type I, with the surrounding sequences highly con-
served (type III sequence, GPRGQOGVMGFO; type II se-
quence, GARGQOGVMGFO, and sequence of the I chain of
type I collagen GARGQAGVMGFO). Note that formation of
Hyp (O) from Pro in the Yaa position of the Gly-Xaa-Yaa trip-
lets is a post-translationalmodification in animal collagens that
does not take place in the bacterial expression system; there-
fore, GVMGFP rather than GVMGFO is present in the recom-
binant bacterial protein.
Two constructs weremade containing either four or six trip-
lets of human type III collagen sequence inserted between two
tandem CL (Gly-Xaa-Yaa)79 domains of bacterial collagen, and
these are denoted as SCl-DDR4 (GPRGQPGVMGFP) or SCl-
DDR6 (GPSGPRGQPGVMGFPGPK) (Fig. 1A). A specific neg-
ative control with a single Phe to Ala replacement was also
constructed. Previous peptide studies indicated that replace-
ment of the critical Phe in the GVMGFP motif by Ala elimi-
nated DDR binding and receptor activation (29, 30); therefore,
a bacterial protein containing six triplets, including this
replacement GPSGPRGQPGVMGAPGPK was also expressed
and denoted as SCl-DDR6 F-A. All recombinant proteins were
expressed in E. coli at 22 °C, and the N-terminal His-tagged
proteinswere purified through a nickel-nitrilotriacetic acid col-
umn (IMAC), yielding 50 mg/liter of collagen proteins. The
purity and identity of the proteins were confirmed by SDS-
PAGE and MALDI-TOF (Fig. 1, B and C; Table 1).
Structural Characterization of Recombinant Bacterial Col-
lagens—Experiments were carried out to confirm that the
insertion of the human collagen sequences did not disrupt the
triple-helical conformation or stability of the chimeric colla-
gens. The CD spectra of all recombinant proteins showed a
characteristic maximumnear 220 nm and aminimumnear 198
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nm, confirming that they adopted a triple-helical conformation
(Fig. 2A). Monitoring the MRE220 nm versus temperature indi-
cated a sharp thermal transition close to 37 °C for all SCl vari-
ants (Fig. 2B and Table 1), with a very small decrease inTmCD of
0.5 °C for the proteins with insertions versus the control. Dif-
ferential scanning calorimetric data of the samples showed sim-
ilar pattern of thermal stabilities (Fig. 2C and Table 1), with
higher TmCAL observed compared with CD likely due to the 10
times faster heating rate (37). The calorimetry enthalpy of SCl-
DDRs also decreased slightly versus control but is comparable
with other SCl variants with 4–6 triplet human collagen
sequence insertions (19).
Trypsin digestion was performed to investigate whether a
tight triple helix was maintained at the inserted human
sequences. After a 2-h digestion at 25 °C, the globular V domain
of SCl was cleaved off, yielding bands with decreased mobility
on SDS-PAGE, corresponding to the size of the CL-CL unit
(Fig. 2D). This indicates that insertions of up to six triplets of
DDR-binding site sequences into the CL-CL protein did not
alter the triple-helical conformation, as it remained resistant to
trypsin digestion. These results confirm that the SCl-DDR4,
SCl-DDR6, and SCl-DDR6 F-A proteins form a typical triple-
helical structure.
Dynamic light scattering was used to analyze the particle
sizes of the bacterial collagens and to detect potential soluble
aggregation of the SCl-DDR solution. The hydrodynamic radii
(Rh) of all SCl proteins were 44	 1.2 nm (Table 1), which is
consistent with the previously reported values. These results
indicate that proteins with the DDR-binding site insertions did
not form aggregates under these conditions.
DDR1 and DDR2 Bind to SCl-DDR Proteins—Recombinant
DDR ectodomain constructs, DDR1-Fc and DDR2-Fc, were
FIGURE 1. Production of recombinant collagen-like protein with DDR-
binding sequences (SCl-DDR). A, schematic diagram of SCl construct with
four or six triplet DDR-binding sequence insertions. B, SDS-PAGE showing the
purity of the recombinant collagens after His tag column purification. Lane 1,
SCl-DDR4; lane 2, SCl-DDR6; lane M, Novex Sharp protein standard (Invitro-
gen); molecular mass is indicated in kDa. Note that collagen proteins always
migrate slower in SDS-PAGE than expected on the basis of protein standards.
C, MALDI-TOF mass spectrometry of SCl-DDR4 (left) and SCl-DDR6 (right),
showing the molecular mass of the proteins is in good agreement with that
expected (Table 1). a.u., arbitrary units.
FIGURE 2. Structural and thermal analysis of SCl-DDR recombinant colla-
gens. A, circular dichroismwavelength spectra of the recombinant collagens
showing triple helix formation. Color code is as follows: SCl (blue); SCl-DDR4
(red); SCl-DDR6 (green); SCl-DDR6 F-A (purple). B, circular dichroism tempera-
ture scans showing the unfolding profiles of all recombinant collagens. Color
code is the same as in A. C, differential scanning calorimetry of SCl (blue),
SCl-DDR4 (red), and SCl-DDR6 (green) showing heat capacity as a function of
temperature. Areas under the curve indicate the calorimetric enthalpy.D, 2-h
trypsin digestion (T) showing resistance of the triple-helical domain against
enzyme digestion. Proteins were analyzed by SDS-PAGE. Lane M, Novex
Sharp protein standard (Invitrogen); molecular mass is indicated in kDa.MRE,
mean residue ellipticity.
TABLE 1
Characterization of the recombinant bacterial collagen constructs
Molecular massa CD DSC
DLS, Rh
Binding affinity (apparent Kd)d
Calculated Observed MRE200 nmb TmCD Enthalpyc TmCAL DDR1 DDR2 VWF
kDa kDa °C °C nm nM nM g/ml
SCI 55734.39 ND 4677 37.1 4217 38.0 45.1 – – –
SCI-DDR4 56429.18 56295 3456 36.4 3993 37.0 44.9 53.3	 7.1 81.2	 17.2 1.2	 0.12
SCI-DDR6 56952.77 56819 4307 36.6 3818 37.2 42.4 66.0	 8.8 69.7	 7.4 1.2	 0.09
SCI-DDR6F-A 56876.67 ND 2913 36.5 ND ND ND – – –
Bovine Collage III ND ND ND ND ND ND ND 15.2	 0.9 20.0	 1.9 1.0	 0.09
a Calculated mass is based on the amino acid sequence in the open reading frame of each construct. Observed mass is acquired fromMALDI-TOF results.
b Unit for the mean residue ellipticity of the CD is degreescm2dmol1.
c Unit for the calorimetric enthalpy of the DSC is kJmol1K1.
d The apparent Kd values are calculated based on binding curves obtained from the solid-state binding assays; they are good for internal comparison but do not represent the
accurate binding constant between the ligand and receptor. Cells with dash symbols indicate no binding. Cells with ND indicate value not determined for that sample.
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used to measure binding to immobilized collagens and SCl-
DDR proteins (Fig. 3, A and B). As expected, the original SCl
construct without an insertion did not bind DDR1 or DDR2,
whereas the insertion of the four or six tripeptide sequence
containing the GVMGFP motif led to DDR binding for both
SCl-DDR4 and SCl-DDR6. The binding signal for these con-
structs was about 30–50% lower than those seen for the control
native type I and type III collagens. DDR binding was seen only
when the recombinant proteins were in their native triple-heli-
cal state; no binding was seen following denaturation, in agree-
ment with the receptors’ binding specificities that are strictly
dependent on a native triple-helical conformation (24, 25, 28).
The SCl-DDR6 F-A construct showed no binding, consistent
with the peptide studies showing Phe is required at theGFP site
(29, 30). Initial binding assays were carried out at a DDR con-
centration of 20 g/ml (220 nM), and this was expanded to
obtain dose-response curves using receptor concentrations
from 0 to 60 g/ml (0–667 nM) for DDR1-Fc (Fig. 3C) and
DDR2-Fc (Fig. 3D). SCl-DDR4 and SCl-DDR6 had similar
apparent Kd values for both DDR1-Fc and DDR2-Fc, which
were about 3–4 times higher than those for collagen III binding
to DDR1-Fc or DDR2-Fc (Table 1), and there was a modest
reduction in Bmax (maximal binding) relative to collagen III.
SCl-DDR Proteins Are Ligands for von Willebrand Factor—
TheDDR-bindingmotif overlaps with the high affinity-binding
site for VWF on collagen type III (RGQOGVMGFO) (38). As
this sequence (i.e. RGQPGVMGFP, without Hyp) is contained
in both SCl-DDR4 and SCl-DDR6, we tested the proteins for
their ability to bind toVWF. Fig. 4 shows dose-dependent bind-
ing of VWF to both SCL-DDR4 and SCl-DDR6. In this case,
collagen III, SCl-DDR4, and SCl-DDR6 did not differ in their
affinity to VWF (Table 1). In agreement with the collagen bind-
ing specificity of VWF (38), VWF did not bind to denatured
collagens or the SCl-DDR6 F-A construct (Fig. 4). This shows
that the same sequence GPRGQPGVMGFP in a bacterial col-
lagen context enables binding to VWF as well as to the DDRs,
consistent with the peptide findings. These data demonstrate
that our engineered SCl proteins have the expected binding
characteristics for the inserted binding module.
SCl-DDR Proteins Do Not Induce DDR Activation—Because
SCl-DDR4 and SCl-DDR6 bound to DDR1 and DDR2 in the
solid-phase binding assays, experiments were carried out to
determine whether these chimeric recombinant constructs
could promote receptor activation in HEK293 cells that tran-
siently express full-length DDR1 or DDR2. Collagen binding to
the extracellular discoidin homology domain induces activa-
tion of the intracellular DDR tyrosine kinase domain, which is
manifested by autophosphorylation of cytoplasmic Tyr resi-
dues (24, 25). The presence of Tyr phosphorylationwas assayed
byWestern blotting of cell lysates, as described previously (28–
30). Collagen type I (at 10 g/ml or 35 nM)6 induced a clear
phosphorylation signal for both DDR1 and DDR2, as expected
(Fig. 5A). In sharp contrast, no DDR activation above back-
ground was observed when cells were incubated with either
6 The concentrations of animal collagens, the SCl-DDR collagen constructs,
and the triple-helical peptides are expressed in terms of molarity of trimer
(based on single chain molecular mass of animal collagen at 95 kDa,
SCl-DDR at 57 kDa, and peptide molecular masses depending on their
sequence).
FIGURE3.Solid-phasebindingassayof recombinantDDR1-FcorDDR2-Fc
to recombinant SCl-DDR collagens. A and B, SCl-DDR constructs in both
triple-helical (gray) or denatured (black) states were immobilized on 96-well
plates and incubatedwith 20g/ml (220nM), ofDDR1-Fc (A) orDDR2-Fc (B).
Bound proteins were detected with anti-Fc antibodies and measured as ab-
sorbance at 450 nm. C and D, dose response of DDR1-Fc (C) and DDR2-Fc (D)
to collagens adsorbed onto plastic plates. Color code is as follows: collagen
type III (gray); SCl-DDR4 (red); SCl-DDR6 (green); SCl (blue); SCl-DDR6 F-A (pur-
ple); and denatured collagen type III (open gray symbols). Data obtained with
denaturedSCl-DDR4 andSCl-DDR6overlapwith thoseof SCl andSCl-DDR6 F-A.
Data were fitted in GraphPad Prism using a non-linear fit (one site, specific
binding).
FIGURE 4.Solid-phasebindingassayofVWF to recombinant SCl-DDRcol-
lagens.A,SCl-DDRconstructs inboth triple-helical (gray) or denatured (black)
stateswere immobilizedon96-well plates and incubatedwith 20g/ml VWF.
B, dose response of VWF to collagens adsorbed onto 96-well plates. Bound
proteinwas detectedwith anti-VWF antibodies andmeasured as absorbance
at 450 nm. Color code is as follows: collagen type III (gray); SCl-DDR4 (red);
SCl-DDR6 (green); SCl (blue); SCl-DDR6 F-A (purple). Data obtained with dena-
tured collagens are obscured by those obtainedwith SCl-DDR6 F-A. Data were
fitted in GraphPad Prism using a non-linear fit (one site, specific binding).
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SCl-DDR4 or SCl-DDR6 using standard incubation conditions
at 37 °C. When the initial concentration of 100 g/ml (0.6 M)
recombinant collagen failed to activate the DDRs, the concen-
tration was increased to the highest testable concentration of
800 g/ml (4.7 M), but no phosphorylation was observed.
Because the triple-helical conformation is required for DDR
binding, and activation at 37 °C is close to the melting temper-
ature of the bacterial collagen constructs, it is possible that lack
of DDR activation by the bacterial collagen constructs was due
to denaturation of the collagens during the 90-min incubation
at 37 °C. The activation assays were therefore also carried out at
lower temperatures, to avoid possible unfolding of triple heli-
ces. Type I collagen induced strong DDR autophosphorylation
when cells were incubated at 23 °C, but the bacterial collagen
constructs did not induce phosphorylation above background
of either DDR1 or DDR2 (Fig. 5B). These data suggest that
although the SCl-DDR proteins can bind to the DDRs, they do
not act as receptor agonists.
Effect of Proline Hydroxylation on DDR Binding and Acti-
vation—Because the recombinant collagen expressed in E. coli
is not hydroxylated on proline, it is possible that the absence of
Hyp affects DDR binding and receptor activation. Introducing
post-translational hydroxylation of Pro in this recombinant
bacterial system is complicated, because under aerobic condi-
tions E. coli cells do not biosynthesize or transport L-ascorbate
into the cytosol (39), which would be required to activate
human prolyl-4-hydroxylase introduced through plasmids.
Experiments based on a previously published strategy to bypass
this requirement (39) have thus far only yielded bacterial colla-
genwith lowHyp levels in our hands. Therefore, experiments to
investigate the effect of Hyp on DDR binding and activation
were carried out on synthetic triple-helical peptides. Two Hyp
are present in the GPRGQOGVMGFODDR-binding sequence
of collagen type III (underlined), and it was previously shown
thatmutation of theHyp toAla in theGQOtriplet did not affect
the binding affinity to DDR1 or DDR2, although a Hyp to Ala
change in the GFO triplet caused a substantial decrease in DDR
binding (29, 30). To further investigate whether it is the Pro
residue itself or the hydroxylation of the Pro that is critical in
the GVMGFO sequence, homologous peptides with GPRGQ-
OGVMGFP and GPRGQOGVMGFO were synthesized and
tested. A control peptide with the sequence GPRGQPGV-
MGFOwas also synthesized, which was expected to bind to the
DDRs with similar affinity to the native sequence. Solid-phase
binding assays showed that the peptide with GPRGQPGV-
MGFO did indeed bind to DDR1-Fc and DDR2-Fc to similar
extents as a peptide with GPRGQOGVMGFO (Fig. 6). In
contrast, GPRGQOGVMGFP resulted in weaker binding to
DDR1-Fc and DDR2-Fc, compared with the native sequence.
Thepeptideswere tested for their ability to induceDDRphos-
phorylation (Fig. 7). Although the GPRGQPGVMGFO peptide
could effectively induce DDR1 or DDR2 phosphorylation when
tested at 50 g/ml (3.9 M) or 100 g/ml (7.9 M), the peptide
with GPRGQOGVMGFP required higher concentrations
FIGURE 5. Recombinant collagens do not induce DDR1 or DDR2 autophosphorylation. Full-length DDR1 (DDR1a isoform) or DDR2 was transiently
expressed in HEK293 cells. After stimulation for 90min with the indicated collagen samples at 37 °C (A) or at 23 °C (B), cell lysates were analyzed by SDS-PAGE
andWestern blotting. Collagen Iwas used at 10g/ml (0.035M), which is the concentration previously established to trigger autophosphorylation; SCl-DDRs
were assayed at 100g/ml (0.6M) initially, which is the concentration previously shown to trigger autophosphorylation for collagen peptides, and later at a
much higher concentration 800 g/ml (4.7 M). For DDR1 samples, the blot was probed with anti-phosphotyrosine mAb 4G10 (upper panel), followed by
stripping and reprobing with anti-DDR1 (lower blot). For DDR2 samples, samples were resolved on two gels. The corresponding blots were probed with
anti-phosphotyrosine mAb 4G10 (upper panel) or anti-DDR2 (lower panel). The positions of molecular mass markers are indicated (in kDa).
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(250g/ml or 19.6M) to stimulate similar levels of DDR1 or
DDR2 autophosphorylation. These results are in keeping with
the reduced binding affinity of GPRGQOGVMGFP compared
withGPRGQOGVMGFO and suggest that the presence of Hyp
in GVMGFO, although important for higher affinity DDR bin-
ding, is not essential to induce DDR phosphorylation Add-
itional peptides contained Pro to Ala substitutions or Hyp to Ala
substitutions in the sequence GPSGPRGQOGVMGFO. Activa-
tion of the DDRs by these peptides was as expected; peptides
with GPSGARGQOGVMGFO or GPSGPRGQAGVMGFO in-
duced DDR phosphorylation to the same extent as GPSGPRG-
QOGVMGFO, in line with their ability to bind DDR1 and
DDR2 to similar extents as peptides with the native sequence
(29, 30). In contrast, a peptide with GPSGPRGQOGVMGFA
drastically reduced DDR binding (29, 30) and receptor activa-
tion (Fig. 7). Compared with collagen, a much higher molar
concentration of these synthetic peptides is required for DDR
activation (4 M peptide versus 0.03 M collagen), but the
reasons for this are not known (29, 30).
Recombinant SCl-DDR as an Inhibitor of DDR Binding and
Activation—Given that the recombinant chimeric collagens
could bind toDDR1 andDDR2, but not activate them, their role
as a potential inhibitor was explored. First, a competitive solid-
phase binding assay was performed to test whether the recom-
binant collagens could inhibit DDR1 or DDR2 binding to
immobilized type III collagen (Fig. 8). Denatured collagens as
well as the original SCl, with no insertion, showed only negligi-
ble inhibition. Efficient inhibition was observed when excessive
amounts of native SCl-DDR recombinant collagens were pre-
incubated with DDR1-Fc or DDR2-Fc before addition onto
type III collagen-coatedwells.Maximal inhibitionwas achieved
at 1.3 M (228 g/ml) of recombinant collagens, giving a
molar ratio between dimeric DDR receptors to trimeric recom-
binant collagenmolecules of1:60. Under the same condition,
type I collagen acted as a somewhat more potent inhibitor,
showing inhibitory effects at lower concentrations. The ability
of the recombinant SCl-DDR collagens to inhibit animal colla-
FIGURE 6. Solid-phase binding assays of DDR1-Fc or DDR2-Fc to triple-
helical collagen-mimetic peptides. DDR1-Fc (A) or DDR2-Fc (B) was added
for 3 h to 96-well plates coated with peptides at 10 g/ml. Bound proteins
were detected with anti-Fc antibodies and measured as absorbance at 492
nm. Data were fitted in GraphPad Prism using a non-linear fit (one site, spe-
cific binding).
FIGURE 7. DDR activation by collagen-mimetic peptides. Hyp in GVMGFO
is important but not essential forDDR1orDDR2activation. Full-lengthDDR1a
or DDR2 was transiently expressed in HEK293 cells. After stimulation for 90
min at 37 °Cwith the indicatedpeptide samples, cell lysateswere analyzedby
SDS-PAGE and Western blotting. Peptides were used at 50 g/ml (3.9 M) or
100 g/ml (7.9 M); the peptide without Hyp was also assayed at 250 g/ml
(19.6M).A,DDR1 samples, blot was probedwith anti-phosphotyrosinemAb
4G10 (upper panel), followed by stripping and reprobing with anti-DDR1
(lower blot). B, DDR2 samples, samples were resolved on two gels. The corre-
sponding blots were probed with anti-phosphotyrosine mAb 4G10 (upper
panel) or anti-DDR2 (lower panel). The positions of molecular mass markers
are indicated (in kDa).
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gen binding to DDR suggests potential for inhibition in a bio-
logical setting.
DDR1 is known to support the migration of several types of
cells, and the ability of recombinant SCl-DDR6 protein to
inhibit such migration was investigated using a previously
established Mk migration system where DDR1 could be acti-
vated by fibrillar collagen, which subsequently promoted cell
migration and invasion (36). SCl-DDRwas added, at increasing
concentrations, into the cell culture media to evaluate whether
it could block the binding betweenMk surface DDR1 receptors
and type III collagen, and thus inhibit cell migration or cell
invasion. When SCl-DDR4 or SCl-DDR6 was added at 10, 50,
and 100 g/ml (equals 58, 290, and 580 nM), fewer cells
migrated through the Transwell membrane, compared with
control conditions without adding recombinant collagen (Fig.
9,A–C).When the same concentration of SClwithout insertion
or SCl-DDR6 F-A was added, there was no obvious change in the
number of cells migrating through the membrane. Of note, 1
g/ml (6 nM) of all the bacterial collagens tested did not result
in any reduction of Mk migration. The level of phosphorylated
DDR1 in the Mks plated on collagen type III was also analyzed
by Western blot. In the presence of SCl-DDR4 and of SCl-
DDR6, there was a reduction in the level of phosphorylated
DDR1 to a level comparable with unstimulated Mks as shown
by the level of phosphorylated DDR1 normalized to actin (Fig.
9, D and E). SCl or SCl-DDR6 F-A did not affect the level of
DDR1 phosphorylation. These results suggest that SCl-DDR6
and SCl-DDR4 compete with coated type III collagen for bind-
ing DDR1 on the surface ofMks, thereby preventing the activa-
tion of DDR1 and delaying cell migration in this cell culture
system.
Discussion
We report on a recombinant protein with sequences from
the DDR binding region of human collagen type III inserted
within a triple-helical bacterial collagen context. Collagen, as
the major component of the extracellular matrix, contains
more than 50 biologically active sites that interact with other
extracellular matrix proteins or cell surface receptors and reg-
ulates normal cellular and tissue functions (40). The stringent
requirement of forming triple-helical structures complicates
the analysis of collagen ligand-binding sites. Early studies used
collagen fragments from cyanogen bromide digestion and
rotary shadow electron microscopy to identify the rough loca-
tion of some bioactive sites within collagen. The development
of libraries of overlapping triple-helical peptides, the so-called
collagen Toolkit peptide libraries, allowed a comprehensive
analysis of binding sites within the fibrillar collagens type II and
type III (12) and formed the basis for successful definition of the
minimal binding sites of an increasing number of key collagen
activities, including the DDR-binding sequence used in this
study (29, 30).
Although the development of synthetic triple-helical pep-
tides led to major advances in defining collagen binding activi-
ties, alternative recombinant strategies are valuable for con-
firming the peptide results and allowing their application to
biomaterials. The use of engineered bacterial collagen-like pro-
teins as a complementary approach allows large scale produc-
tion of the recombinant protein by standard protein production
methods and the creation of bioactive hydrogels (5, 6, 41). To
date, several human collagen interaction regions have been
inserted within a recombinant bacterial collagen-like protein,
including the binding sites for different integrins, the binding
site for fibronectin and heparin, and the cleavage site forMMP1
and MMP-13 (11, 18–21). Varying the length of inserted
sequences also allowed definition of the minimally required
collagen sequence of a given activity in this system. Using the
bacterial collagen system raises the possibility of efficient pro-
duction of “plug and play” recombinant collagen-like proteins
containing selected and multiple collagen functions. Here, we
extend the concept of designingmodular collagenwith separate
collagen functionalities by creating a group of recombinant col-
lagen-like molecules to target and regulate DDR signaling.
Recombinant collagens containing DDR-binding sequences
did bind to DDR receptors, as expected, but they differed from
mammalian collagens in their weaker binding affinity and their
inability to stimulate DDR autophosphorylation.
Non-modified SCl did not bind to the DDRs; binding was
dependent on the presence of a DDR-binding sequence and an
intact triple helix, as expected from the strict requirement for
native triple-helical conformation for the DDR-collagen inter-
action. Both SCl-DDR4 and SCl-DDR6 bound DDR1 and
DDR2, but there are small differences in the amount ofmaximal
binding and in the level of inhibition. It is not clear whether
these differences are significant, butwe cannot exclude the pos-
sibility that low inhibition of SCl-DDR4 points to a secondary
binding site in DDR. The dose-response curves of DDR-Fc pro-
teins to SCl constructs showed reduced binding affinity of
recombinant SCl-DDR compared with collagens type I and III
FIGURE8.Competitive inhibitionbySCl-DDRof the interactionsbetween
collagen type III and recombinant DDR2-Fc. Collagen type I, SCl-DDR4, or
SCl-DDR6 were incubated with DDR1-Fc (A) or DDR2-Fc (B) for 1 h at room
temperature before addition to plate-immobilized collagen type III. Bound
DDR-Fcwas detectedwith anti-Fc antibodies andmeasured as absorbance at
450 nm. Color code is as follows: collagen type I (gray); SCl-DDR4 (red); SCl-
DDR6 (green); SCl (blue). Dashed lines show data for the denatured samples.
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(Fig. 3). The most obvious difference between animal collagen
and recombinant collagen is the presence of hydroxyproline in
the former. Our data with synthetic peptides show that Hyp in
the six amino acid-bindingmotif GVMGFO is required for high
affinity DDR binding but that substitution of Hyp with Pro in
the preceding triplet (GPRGQPGVMGFO context) does not
alter binding affinity (Fig. 6). A previous crystal structure of the
DDR2 discoidin domain complexed to a collagen-mimetic pep-
tide showed the Hyp in GVMGFO in the leading chain of the
triple helix participates in a hydrogen bonding network involv-
ing a salt bridge between Arg-105 and Glu-113 of DDR2,
whereas the preceding Hyp makes no contact with DDR2 (31).
It is therefore not surprising that mutation to GVMGFP
reducesDDRbinding, although theGPRGQPGVMGFP substi-
tution has no effect on the DDR-SCl interaction. The presence
of Hyp in the GVMGFO motif is thus critical for high affinity
DDR-collagen interactions.
In contrast, for VWF, it was previously shown that substitu-
tion of Hyp with Ala (GVMGFA context) in a synthetic triple-
helical peptide did not affect VWF binding (38), indicating that
Hyp in the GVMGFOmotif is not involved in binding to VWF.
Consistent with this notion, our SCl-DDR constructs bound to
VWF with similar affinity to that seen for type III collagen (Fig.
4), which likely reflects the lack of involvement of Hyp in VWF
binding.
All previous studies found a correlation between the ability of
different collagen types to bind the DDRs and their ability to
induce receptor activation, as assessed by autophosphorylation
FIGURE 9. SCl-DDRs reduce DDR1 activation on type III collagen and result in decreasedmegakaryocyte migration and invasion. A,Mks were treated
with the indicated concentrations of the SCl-DDR recombinant collagens and allowed to migrate in a trans-well migration chamber coated with type III
collagen for 16h.Mks that passed through the filter in the lower chamberwere counted.B,Mks adheringon the lower side of the Transwell filterwere fixed and
stained with anti-CD61 antibody and then counted by fluorescence microscopy. C, representative images showing Mks that invaded the lower side of the
Transwell filter. Cells were stained with anti-CD61 antibody (red). Nuclei were counterstained with Hoechst 33288 (blue). Scale bar, 50 m. D, DDR1 activation
assay on Mks stimulated with 100 g/ml (580 nM) of the indicated SCl-DDR recombinant collagen and plated on type III collagen-coated wells. Unstimulated
Mks plated on uncoatedwells were used as control. Membranes were probedwith the indicated antibodies. E, densitometry analysis of pDDR1Western blots.
pDDR1/actin ratio was calculated and shown as relative to unstimulated Mk. Data are presented as means	 S.D. of at least three independent experiments.
Asterisks indicate p 0.05.
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of cytoplasmic tyrosine residues (24, 25, 28, 42, 43). This corre-
lation is extended to collagen-mimetic peptides (Fig. 7) (present
study and Refs. 29, 30). It was therefore surprising to see no
receptor activation by the recombinant SCl-DDR proteins,
despite their ability to bind to the DDRs in a specific manner.
The inability to induce transmembrane signaling cannot be
explained by denaturation of the SCl-DDR triple helix, because
no phosphorylation was observed at 23 °C as well as at 37 °C,
although control animal collagens led to a strong phosphoryla-
tion signal at both temperatures. Although a lack of hydroxyl-
ation in GPRGQOGVMGFO reduced binding affinity, peptide
studies showed that hydroxylation was not essential for induc-
ing receptor activation. Higher concentrations of GPRGQOG-
VMGFP peptide were required for DDR activation, compared
with the GPRGQOGVMGFO peptide, but the relative peptide
concentrations required for activation were in line with their
relative affinities.
Because of the reduced binding affinity of the recombinant
collagens compared with animal collagens, higher concentra-
tions of SCl-DDR proteins were tested for DDR activation, but
no significant autophosphorylation was observed, even at 800
g/ml (4.7 M), the highest concentration that was practical in
the cell-based assay following the dilution of the protein stock
into cell culture medium. Synthetic peptides require much
higher concentrations than native collagens to induce DDR
phosphorylation (3–4 M versus 0.02–0.03 M), especially in
the absence ofHyp in theGVMGFOessential sequence, but the
underlying reasons are not clear (29, 30). We cannot exclude
that the failure of our recombinant collagens to induce DDR
phosphorylation is due to an inability to test them at high
enough concentrations, but the unexpected uncoupling
observed between DDR binding and DDR activation may be
related to the unusual nature of DDR activation compared with
other receptor tyrosine kinases. Typical receptor tyrosine
kinases are activatedwith fast kinetics (seconds tominutes after
ligand binding), whereas the DDRs have protracted activation
kinetics and require prolonged incubation with collagen for
kinase activation (24, 25). Despite a detailed understanding of
the DDR1 ectodomain structure and the DDR2-collagen inter-
action (31, 44), very little is known about the molecular mech-
anism of how collagen binding to the DDR discoidin domains
results in activation of the cytoplasmic kinase domain. In par-
ticular, the cellular mechanisms behind the slow kinetics are
unclear. DDR1 binding to animal collagen has been shown to
cluster the receptor on the cell surface with fast kinetics (45). It
is likely that SCl-DDR proteins bind to the DDRs on the cell
surface, but perhaps the bacterial collagen cannot cluster the
receptors in the required fashion or cannot mediate a “second
step” in activation such as the transition from clustered recep-
tors to phosphorylated receptors. Future experiments are
required to address whether SCl-DDR proteins lead to DDR1
clustering on the cell surface. It is currently not established
whether DDR phosphorylation results from interactions with
collagen that has aggregated during the prolonged incubation
times necessary to observe receptor phosphorylation. Possible
reasons why the SCl-DDRproteins cannot activate DDRs could
include the absence of aggregation for the recombinant SCl-
DDR protein, which may be required, or the large number of
charges in the SCl triple helix, which could disrupt or prevent
interactions of the DDRs with molecules on the cell surface,
which may be required for a transition to the phosphorylated
state.
The observation that SCl-DDR proteins bind to the DDR
ectodomain without stimulating receptor transmembrane sig-
naling led to the prediction that they could inhibit collagen-
DDR interactions, whichwas demonstrated in vitro and in a cell
migration system. The ability of SCl-DDR molecules to inter-
fere with DDR-collagen interactions provides a basis for the
generation of recombinant collagen-based biomaterials with
DDR inhibitory properties. Recombinant collagen presents an
attractive alternative to animal collagens for collagen biomate-
rial production, allowing standardized, high yield production
with easy sequence modification. The recombinant collagen
approach has been hindered by the requirement for post-trans-
lational modification of Pro to Hyp, an issue that is largely
avoided in bacterial collagen SCl which forms a stable triple
helix in the absence of Hyp. Biological activities such as integ-
rin, fibronectin, and heparin binding have been conferred on
bacterial collagen through the insertion ofmodular human col-
lagen sequences. This study thus presents the first example
where a modular insertion of the defined DDR-binding
sequence did not fully capture biological functionality. How-
ever, it showed the potential of inserting a human ligand bind-
ing module to inhibit a natural biological activity or process.
The generation of recombinant collagen-based biomaterials
with DDR inhibitory properties could be useful in the study of
the pathological roles of DDR signaling in a number of disease
models where DDR signaling is believed to contribute to dis-
ease progression (22, 26, 27).
Author Contributions—B. A., B. L., A. B., and B. B. designed the
study and wrote the paper. B. A., V. A., D. L. K., and B. L. analyzed
and critically evaluated the results. H. X. andD. G. performed exper-
iments with triple-helical peptides and DDR activation assays in
HEK293 cells. V. A. performed the experiments with megakaryo-
cytes. D. B. synthesized the collagen-mimetic peptides. A. Y. per-
formed early cloning experiments. R. W. F. oversaw the peptide
design and experiments. All authors read and approved the final
version of the manuscript.
Acknowledgments—We thank Dr. John Ramshaw from the Common-
wealth Scientific and Industrial Research Organization of Australia
for bovine type I and III collagen preparations and helpful discussion;
we also thank Dr. David Wilbur from Tufts University Chemistry
Department for allowing us to access the MALDI-TOF MS
equipment.
References
1. Rasmussen, M., and Björck, L. (2001) Unique regulation of SclB–a novel
collagen-like surface protein of Streptococcus pyogenes. Mol. Microbiol.
40, 1427–1438
2. Yu, Z., An, B., Ramshaw, J. A., and Brodsky, B. (2014) Bacterial collagen-
like proteins that form triple-helical structures. J. Struct. Biol. 186,
451–461
3. Mohs, A., Silva, T., Yoshida, T., Amin, R., Lukomski, S., Inouye, M., and
Brodsky, B. (2007) Mechanism of stabilization of a bacterial collagen
triple helix in the absence of hydroxyproline. J. Biol. Chem. 282,
29757–29765
DDR Binding Collagen-like Protein with Inhibitory Function
FEBRUARY 26, 2016•VOLUME 291•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 4353
 at Im
perial College London on M
arch 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
4. Xu, C., Yu, Z., Inouye, M., Brodsky, B., and Mirochnitchenko, O. (2010)
Expanding the family of collagen proteins: recombinant bacterial colla-
gens of varying composition form triple-helices of similar stability. Bio-
macromolecules 11, 348–356
5. Cosgriff-Hernandez, E., Hahn, M. S., Russell, B., Wilems, T., Munoz-
Pinto, D., Browning, M. B., Rivera, J., and Höök, M. (2010) Bioactive
hydrogels based on designer collagens. Acta Biomaterialia 6,
3969–3977
6. Peng, Y. Y., Howell, L., Stoichevska, V.,Werkmeister, J. A., Dumsday, G. J.,
and Ramshaw, J. A. (2012) Towards scalable production of a collagen-like
protein from Streptococcus pyogenes for biomedical applications.Microb.
Cell Fact. 11, 146
7. An, B., Kaplan, D. L., and Brodsky, B. (2014) Engineered recombinant
bacterial collagen as an alternative collagen-based biomaterial for tissue
engineering. Front. Chem. 2, 40
8. Lukomski, S., Nakashima, K., Abdi, I., Cipriano, V. J., Shelvin, B. J., Graviss,
E. A., and Musser, J. M. (2001) Identification and characterization of a
second extracellular collagen-like proteinmade by group A Streptococcus:
control of production at the level of translation. Infect. Immun. 69,
1729–1738
9. Xu, Y., Keene, D. R., Bujnicki, J. M., Höök, M., and Lukomski, S. (2002)
Streptococcal Scl1 and Scl2 proteins form collagen-like triple helices.
J. Biol. Chem. 277, 27312–27318
10. Humtsoe, J. O., Kim, J. K., Xu, Y., Keene, D. R., Höök,M., Lukomski, S., and
Wary, K. K. (2005) A streptococcal collagen-like protein interacts with the
21 integrin and induces intracellular signaling. J. Biol. Chem. 280,
13848–13857
11. Seo, N., Russell, B. H., Rivera, J. J., Liang, X., Xu, X., Afshar-Kharghan, V.,
and Höök, M. (2010) An engineered 1 integrin-binding collagenous se-
quence. J. Biol. Chem. 285, 31046–31054
12. Farndale, R. W., Lisman, T., Bihan, D., Hamaia, S., Smerling, C. S.,
Pugh, N., Konitsiotis, A., Leitinger, B., de Groot, P. G., Jarvis, G. E., and
Raynal, N. (2008) Cell-collagen interactions: the use of peptide Tool-
kits to investigate collagen-receptor interactions. Biochem. Soc. Trans.
36, 241–250
13. Manka, S.W., Carafoli, F., Visse, R., Bihan, D., Raynal, N., Farndale, R.W.,
Murphy, G., Enghild, J. J., Hohenester, E., andNagase, H. (2012) Structural
insights into triple-helical collagen cleavage by matrix metalloproteinase
1. Proc. Natl. Acad. Sci. U.S.A. 109, 12461–12466
14. Erat, M. C., Slatter, D. A., Lowe, E. D., Millard, C. J., Farndale, R. W.,
Campbell, I. D., and Vakonakis, I. (2009) Identification and structural
analysis of type I collagen sites in complex with fibronectin fragments.
Proc. Natl. Acad. Sci. U.S.A. 106, 4195–4200
15. Sekiya, A., Okano-Kosugi, H., Yamazaki, C. M., and Koide, T. (2011)
Pigment epithelium-derived factor (PEDF) shares binding sites in col-
lagen with heparin/heparan sulfate proteoglycans. J. Biol. Chem. 286,
26364–26374
16. Knight, C. G., Morton, L. F., Peachey, A. R., Tuckwell, D. S., Farndale,
R. W., and Barnes, M. J. (2000) The collagen-binding A-domains of
integrins a1b1 and a2b1 recognize the same specific amino acid se-
quence, GFOGER, in native (triple-helical) collagens. J. Biol. Chem.
275, 35–40
17. Jarvis, G. E., Raynal, N., Langford, J. P., Onley, D. J., Andrews, A.,
Smethurst, P. A., and Farndale, R. W. (2008) Identification of a major
GpVI-binding locus in human type III collagen. Blood 111, 4986–4996
18. An, B., DesRochers, T. M., Qin, G., Xia, X., Thiagarajan, G., Brodsky, B.,
and Kaplan, D. L. (2013) The influence of specific binding of collagen-silk
chimeras to silk biomaterials on hMSC behavior. Biomaterials 34,
402–412
19. An, B., Abbonante, V., Yigit, S., Balduini, A., Kaplan, D. L., and Brodsky, B.
(2014) Definition of the native and denatured type II collagen binding site
for fibronectin using a recombinant collagen system. J. Biol. Chem. 289,
4941–4951
20. Peng, Y. Y., Stoichevska, V., Schacht, K.,Werkmeister, J. A., and Ramshaw,
J. A. (2014) Engineering multiple biological functional motifs into a blank
collagen-like protein template from Streptococcus pyogenes. J. Biomed.
Mater. Res. A 102, 2189–2196
21. Yu, Z., Visse, R., Inouye, M., Nagase, H., and Brodsky, B. (2012) Defining
requirements for collagenase cleavage in collagen type III using a bacterial
collagen system. J. Biol. Chem. 287, 22988–22997
22. Leitinger, B. (2014) Discoidin domain receptor functions in physiological
and pathological conditions. Int. Rev. Cell Mol. Biol. 310, 39–87
23. Fu, H. L., Valiathan, R. R., Arkwright, R., Sohail, A., Mihai, C., Kumarasiri,
M., Mahasenan, K. V., Mobashery, S., Huang, P., Agarwal, G., and Frid-
man, R. (2013) Discoidin domain receptors: unique receptor tyrosine ki-
nases in collagen-mediated signaling. J. Biol. Chem. 288, 7430–7437
24. Vogel, W., Gish, G. D., Alves, F., and Pawson, T. (1997) The discoidin
domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1,
13–23
25. Shrivastava, A., Radziejewski, C., Campbell, E., Kovac, L., McGlynn, M.,
Ryan, T. E., Davis, S., Goldfarb, M. P., Glass, D. J., Lemke, G., and Yanco-
poulos, G. D. (1997) An orphan receptor tyrosine kinase family whose
members serve as nonintegrin collagen receptors.Mol. Cell 1, 25–34
26. Valiathan, R. R., Marco, M., Leitinger, B., Kleer, C. G., and Fridman, R.
(2012) Discoidin domain receptor tyrosine kinases: new players in cancer
progression. Cancer Metastasis Rev. 31, 295–321
27. Borza, C. M., and Pozzi, A. (2014) Discoidin domain receptors in disease.
Matrix Biol. 34, 185–192
28. Leitinger, B. (2003) Molecular analysis of collagen binding by the human
discoidin domain receptors, DDR1 and DDR2. Identification of collagen
binding sites in DDR2. J. Biol. Chem. 278, 16761–16769
29. Konitsiotis, A. D., Raynal, N., Bihan, D., Hohenester, E., Farndale, R. W.,
and Leitinger, B. (2008) Characterization of high affinity binding motifs
for the discoidin domain receptor DDR2 in collagen. J. Biol. Chem. 283,
6861–6868
30. Xu, H., Raynal, N., Stathopoulos, S., Myllyharju, J., Farndale, R. W., and
Leitinger, B. (2011) Collagen binding specificity of the discoidin domain
receptors: binding sites on collagens II and III andmolecular determinants
for collagen IV recognition by DDR1.Matrix Biol. 30, 16–26
31. Carafoli, F., Bihan, D., Stathopoulos, S., Konitsiotis, A. D., Kvansakul, M.,
Farndale, R. W., Leitinger, B., and Hohenester, E. (2009) Crystallographic
insight into collagen recognition by discoidin domain receptor 2. Struc-
ture 17, 1573–1581
32. Silva, T., Kirkpatrick, A., Brodsky, B., and Ramshaw, J. A. (2005) Effect of
deamidation on stability for the collagen to gelatin transition. J. Agric. Food
Chem. 53, 7802–7806
33. Yoshizumi, A., Yu, Z., Silva, T., Thiagarajan, G., Ramshaw, J. A., Inouye,
M., and Brodsky, B. (2009) Self-association of Streptococcus pyogenes col-
lagen-like constructs into higher order structures. Protein Sci. 18,
1241–1251
34. Raynal, N., Hamaia, S. W., Siljander, P. R., Maddox, B., Peachey, A. R.,
Fernandez, R., Foley, L. J., Slatter, D. A., Jarvis, G. E., and Farndale, R. W.
(2006) Use of synthetic peptides to locate novel integrin 21-binding
motifs in human collagen III. J. Biol. Chem. 281, 3821–3831
35. Balduini, A., Pallotta, I., Malara, A., Lova, P., Pecci, A., Viarengo, G.,
Balduini, C. L., and Torti, M. (2008) Adhesive receptors, extracellular
proteins and myosin IIA orchestrate proplatelet formation by human
megakaryocytes. J. Thromb. Haemost. 6, 1900–1907
36. Abbonante, V., Gruppi, C., Rubel, D., Gross, O., Moratti, R., and Balduini,
A. (2013) Discoidin domain receptor 1 protein is a novel modulator of
megakaryocyte-collagen interactions. J. Biol. Chem. 288, 16738–16746
37. Persikov, A. V., Xu, Y., and Brodsky, B. (2004) Equilibrium thermal tran-
sitions of collagen model peptides. Protein Sci. 13, 893–902
38. Lisman, T., Raynal, N., Groeneveld, D., Maddox, B., Peachey, A. R., Hui-
zinga, E. G., de Groot, P. G., and Farndale, R. W. (2006) A single high-
affinity binding site for von Willebrand factor in collagen III, identified
using synthetic triple-helical peptides. Blood 108, 3753–3756
39. Pinkas, D. M., Ding, S., Raines, R. T., and Barron, A. E. (2011) Tunable,
post-translational hydroxylation of collagen domains in Escherichia coli.
ACS Chem. Biol. 6, 320–324
40. Kadler, K. (1994) Extracellular matrix. 1: fibril-forming collagens. Protein
Profile 1, 519–638
41. Browning, M. B., Guiza, V., Russell, B., Rivera, J., Cereceres, S., Höök, M.,
Hahn, M. S., and Cosgriff-Hernandez, E. M. (2014) Endothelial cell re-
sponse to chemical, biological, and physical cues in bioactive hydrogels.
Tissue Eng. Part A 20, 3130–3141
DDR Binding Collagen-like Protein with Inhibitory Function
4354 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 9•FEBRUARY 26, 2016
 at Im
perial College London on M
arch 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
42. Leitinger, B., Steplewski, A., and Fertala, A. (2004) The D2 period of col-
lagen II contains a specific binding site for the human discoidin domain
receptor, DDR2. J. Mol. Biol. 344, 993–1003
43. Leitinger, B., andKwan, A. P. (2006) The discoidin domain receptorDDR2
is a receptor for type X collagen.Matrix Biol. 25, 355–364
44. Carafoli, F., Mayer, M. C., Shiraishi, K., Pecheva, M. A., Chan, L. Y., Nan,
R., Leitinger, B., and Hohenester, E. (2012) Structure of the discoidin do-
main receptor 1 extracellular region bound to an inhibitory Fab fragment
reveals features important for signaling. Structure 20, 688–697
45. Mihai, C., Chotani, M., Elton, T. S., and Agarwal, G. (2009) Mapping of
DDR1 distribution and oligomerization on the cell surface by FRET mi-
croscopy. J. Mol. Biol. 385, 432–445
DDR Binding Collagen-like Protein with Inhibitory Function
FEBRUARY 26, 2016•VOLUME 291•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 4355
 at Im
perial College London on M
arch 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Leitinger and Barbara Brodsky
Dominique Bihan, Richard W. Farndale, David L. Kaplan, Alessandra Balduini, Birgit 
Bo An, Vittorio Abbonante, Huifang Xu, Despoina Gavriilidou, Ayumi Yoshizumi,
Functions as a Receptor Inhibitor
Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor
doi: 10.1074/jbc.M115.674507 originally published online December 23, 2015
2016, 291:4343-4355.J. Biol. Chem. 
  
 10.1074/jbc.M115.674507Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/291/9/4343.full.html#ref-list-1
This article cites 45 references, 19 of which can be accessed free at
 at Im
perial College London on M
arch 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
